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Abstract
Genes with similar transcriptional activation kinetics can display very
different temporal mRNA profiles due to differences in transcription time,
degradation rate and RNA processing kinetics. Recent studies have shown
that a splicing-associated RNA production delay can be significant. To
investigate this issue more generally it is useful to develop methods ap-
plicable to genome-wide data sets. We introduce a joint model of tran-
scriptional activation and mRNA accumulation which can be used for in-
ference of transcription rate, RNA production delay and degradation rate
given data from high-throughput sequencing time course experiments. We
combine a mechanistic differential equation model with a non-parametric
statistical modelling approach allowing us to capture a broad range of
activation kinetics, and use Bayesian parameter estimation to quantify
the uncertainty in the estimates of the kinetic parameters. We apply the
model to data from estrogen receptor (ER-α) activation in the MCF-7
breast cancer cell line. We use RNA polymerase II (pol-II) ChIP-Seq
time course data to characterise transcriptional activation and mRNA-
Seq time course data to quantify mature transcripts. We find that 11%
of genes with a good signal in the data display a delay of more than
20 minutes between completing transcription and mature mRNA produc-
tion. The genes displaying these long delays are significantly more likely
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to be short. We also find a statistical association between high delay and
late intron retention in pre-mRNA data, indicating significant splicing-
associated production delays in many genes.
1 Introduction
Induction of transcription through extracellular signalling can yield rapid changes
in gene expression for many genes. Establishing the timing of events during this
process is important for understanding the rate-limiting mechanisms regulating
the response and vital for inferring causality of regulatory events. Several pro-
cesses influence the patterns of mRNA abundance observed in the cell, including
the kinetics of transcriptional initiation, elongation, splicing and mRNA degra-
dation. It was recently demonstrated that significant delays due to the kinetics
of splicing can be an important factor in a focussed study of genes induced by
Tumor Necrosis Factor (TNF-α) [1]. Delayed transcription can play an impor-
tant functional role in the cell; for example, inducing oscillations within negative
feedback loops [2] or facilitating ”just-in-time” transcriptional programmes with
optimal efficiency [3]. It is therefore important to identify such delays and to
better understand how they are regulated. In this contribution we combine RNA
polymerase (pol-II) ChIP-Seq data with RNA-Seq data to study transcription
kinetics of estrogen receptor signalling in breast cancer cells. Using an unbiased
genome-wide modelling approach we find evidence for large delays in mRNA
production in 11% of the genes with a quantifiable signal in our data. A statis-
tical analysis of genes exhibiting large delays indicates that splicing kinetics is
a significant factor and can be the rate-limiting step for gene induction.
A high-throughput sequencing approach is attractive as it gives broad cover-
age and thus allows us to uncover the typical properties of the system. However,
high-throughput data are associated with significant sources of noise and the
temporal resolution of our data is necessarily reduced compared to previous
studies using more focussed PCR-based assays [1, 4]. We have therefore devel-
oped a statistically efficient model-based approach for estimating the kinetic
parameters of interest. We use Bayesian estimation to provide a principled as-
sessment of the uncertainty in our inferred model parameters. Our model can be
applied to all genes with sufficiently strong signal in both the mRNA and pol-II
data with only mild restrictions on the shape of the transcriptional activation
profile (1814 genes here).
A number of other works studying transcription and splicing dynamics (e.g. [1,
5, 6]) forgo detailed dynamical modelling, which limits their ability to properly
account for varying mRNA half-lives. Our statistical model incorporates a lin-
ear ordinary differential equation of transcription dynamics, including mRNA
degradation. Similar linear differential equation models have been proposed as
models of mRNA dynamics previously [4,7,8], but assuming a specific paramet-
ric form for the transcriptional activity. In contrast, we apply a non-parametric
Gaussian process framework that can accommodate a quite general shape of
transcriptional activity. As demonstrated previously [9–11], the linearity of the
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Figure 1: A cartoon illustrating the underlying biology and data gathering at a
single time point (left) and time series modelling (right). The data come from
pol-II ChIP-seq, summarised over the last 20% of the gene body, and RNA-seq
computationally split to pre-mRNA and different mRNA transcript expression
levels. The modelling on the right shows the effect of changing mRNA half-life
(t1/2) or RNA production delay (∆) on the model response: both induce a delay
on the mRNA peak relative to the pol-II peak, but the profiles have otherwise
distinct shapes.
differential equation allows efficient exact Bayesian inference of the transcrip-
tional activity function. Before presenting our results we outline our modelling
approach.
2 Model-based inference of transcriptional de-
lays
Our modelling approach is summarised in Fig. 1. We model the dynamics of
transcription using a linear differential equation,
dm(t)
dt
= βp(t−∆)− αm(t) , (1)
where m(t) is the mature mRNA abundance and p(t) is the transcription rate
at the 3’ end of the gene at time t which is scaled by a parameter β since we do
not know the scale of our p(t) estimates. The parameter ∆ captures the delay
between transcription completion and mature mRNA production. We refer to
this as the RNA production delay, defined as the time required for the poly-
merase to disengage from the pre-mRNA and be fully processed into a mature
transcript. The parameter α is the mRNA degradation rate which determines
the mRNA half-life (t1/2 = ln 2/α). We infer all model parameters (α, β, ∆,
the noise variance and parameters of the Gaussian process covariance function
discussed below) using a Markov chain Monte Carlo (MCMC) procedure. The
posterior distribution of the model parameters quantifies our uncertainty and
we use percentiles of the posterior distribution when reporting credible regions
around the mean or median values.
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Figure 2: Left: Heat map of inferred pol-II and mRNA activity profiles after
MCF7 cells are stimulated with estradiol. Genes with sufficient signal for mod-
elling are sorted by the time of peak pol-II activity in the fitted model. Right:
Examples of fitted model for six genes. For each gene, we show the fit using
the pol-II ChIP-Seq data (collected from the final 20% of the transcribed re-
gion) representing the transcriptional activity p(t) (see Eqn. (1)), and using the
RNA-seq data to represent gene expression m(t). Solid red/green lines show
the mean model estimates for the pol-II/mRNA profiles respectively with asso-
ciated credible regions. In each case we show the posterior distribution for the
inferred delay parameter ∆ to the right of the temporal profiles. Note that the
final measurement times are very far apart (the x-axis is compressed to aid vi-
sualisation) leading to high uncertainty in the model fit at late times. However,
this does not significantly affect the inference of delays for early induced genes.
We measure the transcriptional activity p(t) using RNA polymerase (pol-II)
ChIP-Seq time course data collected close to the 3’ end of the gene (reads lying
in the last 20% of the transcribed region). Our main assumption is that pol-II
abundance at the 3’ end of the gene is proportional to the production rate of
mature mRNA after a possible delay ∆ due to disengaging from the polymerase
and processing. The mRNA abundance is measured using RNA-Seq reads map-
ping to annotated transcripts, taking all annotated transcripts into account and
resolving mapping ambiguities using a probabilistic method [12] (see Methods
Section for details). As we limit our analysis to pol-II data collected from the
3’-end of the transcribed region, we do not expect a significant contribution to ∆
from transcriptional delays when fitting the model. Such transcriptional delays
have recently been studied by modelling transcript elongation dynamics using
pol-II ChIP-Seq time course data [13] and nascent mRNA (GRO-Seq) data [14]
in the same system. Here we instead focus on production delays that can occur
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after elongation is essentially complete.
Existing approaches to fitting models of this type have assumed a parametric
form for the activation function p(t) [4, 7, 8]. We avoid restricting the function
shape by using a non-parametric Bayesian procedure for fitting p(t). We model
p(t) as a function drawn from a Gaussian process which is a distribution over
functions. The general properties of functions drawn from a Gaussian process
prior are determined by a covariance function which can be used to specify
features such as smoothness and stationarity. We choose a covariance function
that ensures p(t) is a smooth function of time since our data are averaged across
a cell population. Our choice of covariance function is non-stationary and has
the property that the function has some persistence and therefore tends to stay
at the same level between observations (see Supplementary Material for further
details). The advantage of using a non-parametric approach is that we only
have to estimate a small number of parameters defining the covariance function
(two in this case, defining the amplitude and time-scale of the function). If we
were to represent p(t) as a parametrised function we would have to estimate a
larger number of parameters to describe the function with sufficient flexibility.
The Bayesian inference procedure we use to associate each estimated parameter
with a credible region would be more challenging with the inclusion of these
additional parameters.
We have previously shown how to perform inference over differential equa-
tions driven by functions modelled using Gaussian processes [9–11]. The main
methodological novelty in the current work is the inclusion of the delay term in
equation (1) and the development of a Bayesian inference scheme for this and
other model parameters. In brief, we cast the problem as Bayesian inference
with a Gaussian process prior distribution over p(t) that can be integrated out
to obtain the data likelihood under the model in Eqn. (1) assuming Gaussian ob-
servation noise. This likelihood function and its gradient are used for inference
with a Hamiltonian MCMC algorithm [15] to obtain a posterior distribution
over all model parameters and the full pol-II and mRNA functions p(t) and
m(t).
3 Results
We model the transcriptional response of MCF-7 breast cancer cells after stimu-
lation by estradiol to activate estrogen receptor (ER–α) signalling. Fig. 2 shows
the inferred pol-II and mRNA profiles for all genes with sufficient signal for
modelling, along with some specific examples of fitted models and estimated
delay parameters. Before discussing these results further below, we describe the
application of our method to realistic simulated data to assess the reliability of
our approach for parameter estimation under a range of conditions.
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Figure 3: Boxplots of parameter posterior distributions illustrating parameter
estimation performance on synthetic data for the delay parameter ∆. The strong
black lines indicate the ground truth used in data generation. The box extends
from 25th to 75th percentile of the posterior distribution while the whiskers
extend from 9th to 91st percentile. The results show that delay estimates are
accurate and reliable, with the true value always in the high posterior density
region.
3.1 Simulated data
We applied our method to data simulated from the model in Eqn. (1) using a p(t)
profile inferred using pol-II data from the TIPARP gene (gene c in Fig. 2; see
Supplementary Material for further details over the simulated data). We simu-
lated data using different values of α and ∆ to test whether we can accurately
infer the delay parameter ∆. Fig. 3 shows the credible regions of ∆ for different
ground truth levels (horizontal lines) and for different mRNA degradation rates
(half-lives given on the x-axis). The results show that ∆ can be confidently
inferred with the ground truth always lying within the central part of the cred-
ible region. The maximum error in posterior median estimates is less than 10
min and when positive, the true value is always above the 25th percentile of
the posterior. We observed that as the mRNA half-life increases, our confidence
in the delay estimates is reduced. This is because the mRNA integrates the
transcriptional activity over time proportional to the half-life leading to a more
challenging inference problem. We also note that inference of the degradation
parameter α is typically more difficult than inference of the delay parameter
∆ (see Fig. S1). However, a large uncertainty in the inferred degradation rate
does not appear to adversely affect the inference of the delay parameters which
are the main focus here. More time-points, or a different spacing of time points,
would be needed to accurately infer the degradation rates. Additional results
of delay estimation in a scenario where the simulated half-life changes during
the time course are presented in Fig. S2. These results demonstrate that the
obtained delay estimates are reliable even in this scenario.
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3.2 Estrogen receptor signalling
We applied our method to RNA-Seq and pol-II ChIP-Seq measurements from
MCF-7 cells stimulated with estradiol to activate ER-α signalling (see Methods
section). The measurements were taken from cells extracted from the same pop-
ulation to ensure that time points are directly comparable across technologies.
Example fits of our model are shown in Fig. 2. The examples show a number
of different types of behaviour ranging from early induced (a-c) to late induced
(d-f), and from very short delay (a, d, e) to longer delays (b, c, f). Example
(e), ECE1, is illuminating because visual inspection of the profiles suggests a
possible delay, but a more likely explanation according to our model is a longer
mRNA half-life and the posterior probability of a long delay is quite low. In-
deed, it is well known that differences in stability can lead to delayed mRNA
expression [16] and therefore delays in mRNA expression peak relative to pol-II
peak time are not sufficient to indicate a production delay. Changes in splic-
ing can be another potential confounder, but our transcript-based analysis of
RNA-seq data can account for that. An example of how more naive RNA-seq
analysis could fail here is presented in Fig. S3.
The parameter estimates of the models reveal a sizeable set of genes with
strong evidence of long delays between the end of transcription and production
of mature mRNA. We were able to obtain good model fits for 1864 genes. We
excluded 50 genes with posterior median delay ¿120 min, as these are unreliable
due to sparse sampling late in the time course, which is apparent from broad
delay posterior distributions. Out of the remaining 1814 genes with reliable
estimates, 204 (11%) had a posterior median delay larger than 20 min between
pol-II activity and mRNA production while 98 genes had the 25th percentile of
delay posterior larger than 20 min, indicating confident high delay estimates.
A histogram of median delays is shown in Fig. 4 (left). The 120 min long delay
cut-off was selected by visual observation of model fits which were generally
reasonable for shorter delays. Note that late time points in our data set are
highly separated due to the exponential time spacing used and thus the model
displays high levels of uncertainty between these points (see Fig. 2). Therefore
genes displaying confident delay estimates are typically early-induced such that
time points are sufficiently close for a confident inference of delay time. Our
Bayesian framework makes it straightforward to establish the confidence of our
parameter estimates.
3.3 Genomic features associated with long-delay genes
Motivated by previous studies [5, 6, 17] we investigated statistical association
between the observed RNA production delay and genomic features related to
splicing. We found that genes with a short pre-mRNA (Fig. 5, left panel) are
more likely to have long delays. We also find that genes where the ratio of the
last intron’s length in the longest annotated transcript over the total length of
the transcript is large (Fig. 5, right panel) are also more likely to have long
delays, but this effect appears to be weaker. These two genomic features, short
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Figure 4: Left: A histogram of delay posterior medians from 1864 genes found
to fit the model well. Estimated delays larger than 120 min are considered
unreliable and are grouped together. These 50 genes were excluded from fur-
ther analysis, leaving 1814 genes for the main analysis. Right: Estimated gene
transcriptional delay for the longest transcript plotted against the estimated
posterior median RNA production delay. The transcriptional delay is estimated
assuming each gene follows the median transcriptional velocity measured in
Ref. [14]. The solid line corresponds to equal delays.
pre-mRNA and relatively long last introns, are positively correlated, making it
more difficult to separate their effects. To do so, Fig. S6 shows versions of the
right panel of Fig. 5 but only including genes with pre-mRNAs longer than 10 kb
or 30 kb. The number of genes with long last introns in these sets is smaller and
the resulting p-values are thus less extreme, but the general shape of the curves
is the same. We did not find a significant relationship with the absolute length
of the last intron. This may be because the two observed effects would tend to
cancel out in such cases. We also checked if exon skipping is associated with long
delays as previously reported [6]. The corresponding results in Fig. S7 show no
significant difference in estimated delays in genes with and without annotated
exon skipping.
3.4 Analysis of the intronic read and pol-II distribution
We investigated whether there was evidence of differences in the pattern of
splicing completion for long-delay genes. To quantify this effect, we developed a
pre-mRNA end accumulation index: the ratio of intronic reads in the last 50%
of the pre-mRNA to the intronic reads in the first 50% at late (80-320 min)
and early (10-40 min) times. Fig. 6 shows that genes with a long estimated
delay display an increase in late intron retention at the later times. There
is a statistically significant difference in the medians of index values for short
and long delay genes (p < 0.01, Wilcoxon’s rank-sum test p-values for different
short/long delay splits are shown in Fig. 6). The example on the left of Fig. 6,
DLX3, is a relatively short gene of about 5 kb and thus differences over time
cannot be explained by the time required for transcription to complete. The
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Figure 5: Tail probabilities for delays. Left: genes whose longest pre-mRNA
transcript is short (m is the length from transcription start to end). Right: genes
with relatively long last introns (f is the ratio of the length of the last intron
of the longest annotated transcript of the gene divided by the length of that
transcript pre-mRNA). The fraction of genes with long delays ∆ is shown by
the red and blue lines (left-hand vertical axis). In both subplots, the black curve
denotes the p-values of Fisher’s exact test for equality of fractions depicted by
the red and blue curves conducted separately at each point (right-hand vertical
axis) with the dashed line denoting p < 0.05 significance threshold. Similar
plots for other values of m and f as well as different gene filter setups are given
in Figs. S4–S5.
corresponding analysis for pol-II ChIP-seq reads as well as GRO-seq reads is in
Fig. S8. It shows a clear delay-associated accumulation to the last 5% nearest
to the 3’ end, while for pol-II in the last 50% the accumulation is universal.
These results suggest our short delay genes tend to be efficiently spliced while
long delay genes are more likely to exhibit delayed splicing towards the 3’ end.
There is also evidence of some accumulation of pol-II near the 3’ end although
the effect appears relatively weak. We note that Grosso et al. [18] identified
genes with elevated pol-II at the 3’-end which were found to be predominantly
short, consistent with our set of delayed genes, and with nucleosome occupancy
consistent with pausing at the 3’ end.
3.5 Relative importance of production and elongation de-
lays
To better understand what are the rate-limiting steps in transcription dynamics,
we assessed the relative importance of the observed RNA production delays in
comparison to transcriptional delays due to elongation time. We estimated elon-
gation times for each gene using assumed transcriptional velocity corresponding
to the 2.1 kb/min median estimate from [14] combined with the length of the
longest annotated pre-mRNA transcript. Others (e.g. [13]) have reported higher
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Figure 6: Left: We show the density of RNA-Seq reads uniquely mapping to
the introns in the DLX3 gene, summarised in 200 bp bins. The gene region
is defined from first annotated transcription start until the end of last intronic
read. The ratio of the number of intronic reads after and before the midpoint
of the gene region is used to quantify the 3’ retention of introns. The pre-
mRNA end accumulation index is the difference between averages of this ratio
computed over late times (80-320 min) and early times (10-40 min). Right:
Differences in the mean pre-mRNA accumulation index (left-hand vertical axis)
in long delay genes (blue) and short delay genes (red) as a function of the cut-off
used to distinguish the two groups (horizontal axis). Positive values indicate
an increase in 3’ intron reads over time. The black line shows the p-values of
Wilcoxon’s rank sum test between the two groups at each cut-off (right-hand
vertical axis).
velocities, so this approach should provide reasonable upper bounds on actual
elongation time for most genes. A comparison of these delays with our posterior
median delay estimates is shown in Fig. 4 (right). The figure shows the major-
ity of genes with short production delays and moderate elongation time in the
top-left corner of the figure, but 14.3% (260/1814) of genes have a longer RNA
production delay than elongation time.
4 Discussion
Through model-based coupled analysis of pol-II and mRNA time course data
we uncovered the processes shaping mRNA expression changes in response to
estrogen receptor signalling. We find that a large number of genes exhibit
significant production delays. We also find that delays are associated with short
overall gene length, relatively long final intron length and increasing late-intron
retention over time. Our results support a major role for splicing-associated
delays in shaping the timing of gene expression in this system. Our study
complements the discovery of similarly large splicing-associated delays in a more
focussed study of TNF-induced expression [1] indicating that splicing delays are
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likely to be important determinants of expression dynamics across a range of
signalling pathways.
It is known that splicing can strongly influence the kinetics of transcrip-
tion. Khodor et al. carried out a comparative study of splicing efficiency in fly
and mouse and found a positive correlation between absolute gene length and
splicing efficiency [5]. This suggests that efficient co-transcriptional splicing is
facilitated by increased gene length and is consistent with our observation that
delays are more common in shorter genes. In these genes it appears that the ma-
ture mRNA cannot be produced after transcription until splicing is completed;
it is splicing rather than transcription that is the rate-limiting step for these
genes. In the same study it was also observed that introns close to the 3’-end of
a gene are less efficiently spliced which is consistent with our observation that
the relative length of the final intron may impact on splicing delays. A fur-
ther theoretical model supporting a link between long final introns and splicing
inefficiency was recently suggested in Ref. [19], but it is unclear if it can fully
explain the observed relationships.
Our model assumes a constant mRNA degradation rate which may be un-
realistic. Given the difficulty of estimating even a single constant degradation
rate for simulated data where the true rate is constant, it seems infeasible to
infer time-varying rates with the current data. On the other hand, estimated
delays were quite reliably inferred even when we simulated data with a time-
varying degradation rate (Fig. S2), and hence the potentially incorrect degra-
dation model should not affect the main results significantly.
It is important to differentiate the delays found here with transcriptional de-
lays required for pol-II elongation to complete. Elongation time can be a signifi-
cant factor in determining the timing of gene induction and elongation dynamics
has been modelled using both pol-II ChIP-Seq [13] and nascent RNA (GRO-
Seq) [14] time course measurements in the system considered here. However, in
this study we limited our attention to pol-II data at the 3’–end of the gene, i.e.
measuring polymerase density changes in the region where elongation is almost
completed. Therefore, we will not see transcription delays in our data and the
splicing-associated delays discussed above are not related to elongation time.
Indeed, the splicing-associated delays observed here are more likely to affect
shorter genes where transcription completes rapidly. These splicing-associated
delays are much harder to predict from genomic features than transcriptional
delays, which are mainly determined by gene length, although we have shown
an association with final intron length and gene length. In the future it would
be informative to model data from other systems to establish associations with
system-specific variables (e.g. alternative splice-site usage) and thereby uncover
context-specific mechanisms regulating the delays that we have observed here.
4.1 Availability
Raw data are available at GEO (accession GSE62789). A browser of all model
fits and delay estimates is available at http://ahonkela.users.cs.helsinki.fi/pol2rna/.
Code for reproducing the experiments is available at
11
https://github.com/ahonkela/pol2rna.
5 Methods
5.1 Data acquisition and mapping
MCF-7 breast cancer cells were stimulated with estradiol (E2) after being placed
in estradiol free media for three days, similarly as previously described [13]. We
measured pol-II occupancy and mRNA concentration from the same cell pop-
ulation collected at 10 time points on a logarithmic scale: 0, 5, 10, 20, 40, 80,
160, 320, 640 and 1280 min after E2 stimulation. At each time point, the pol-II
occupancy was measured genome-wide by ChIP-seq and mRNA concentration
using RNA-Seq. Raw reads from the ChIP-Seq data were mapped onto the
human genome reference sequence (NCBI build37) using the Genomatix Min-
ing Station (software version 3.5.2; further details in Supplementary Material).
On average 84.0% of the ChIP-Seq reads were mapped uniquely to the genome.
The RNA-seq reads were mapped using bowtie to a transcriptome constructed
from Ensembl version 68 annotation allowing at most 3 mismatches and ignor-
ing reads with more than 100 alignments. The transcriptome was formed by
combining the cDNA and ncRNA transcriptomes with pre-mRNA sequences
containing the full genomic sequence from the beginning of the first annotated
exon to the end of the last annotated exon. On average 84.7% of the RNA-seq
reads were mapped.
5.2 RNA-seq data processing
mRNA concentration was estimated from RNA-seq read data using BitSeq [12].
BitSeq is a probabilistic method to infer transcript expression from RNA-seq
data after mapping to an annotated transcriptome. We estimated expression
levels to all entries in the transcriptome, including the pre-mRNA transcripts,
and used the sum of the mRNA transcript expressions in FPKM units to esti-
mate the mRNA expression level of a gene. Different time points of the RNA-seq
time series were normalised using the method of [20].
5.3 Pol-II ChIP-seq data processing
The ChIP-seq data were processed into time series summarising the pol-II oc-
cupancy at each time point for each human gene. We considered the last 20%
of the gene body nearest to the 3’-end. The gene body was defined from the
start of the first exon to the end of the last exon in Ensembl 68 annotation.
The data were subject to background removal and normalisation of time points.
(Full details in the Supplementary Material.)
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5.4 Filtering of active genes
We removed genes with no clear time-dependent activity by fitting time-dependent
Gaussian process models to the activity curves and only keeping genes with
Bayes factor at least 3 in favour of the time-dependent model compared to a
null model with no time dependence. We also removed genes that had no pol-II
observations at 2 or more time points. This left 4420 genes for which we fitted
the models.
5.5 Modelling and parameter estimation
We model the relationship between pol-II occupancy and mRNA concentration
using the differential equation in Eqn. (1) which relates the pol-II time series
p(t) and corresponding mRNA time series m(t) for each gene. We model p(t)
in a nonparametric fashion by applying a Gaussian Process (GP) prior over the
shapes of the functions. We sightly modify the model in Eqn. (1) by adding a
constant β0 to account for the limited depth of pol-II ChIP-Seq measurements,
dm(t)
dt
= β0 + βp(t−∆)− αm(t) (2)
This differential equation can be solved for m(t) as a function of p(t) in closed
form. The pol-II concentration function p(t) is represented as a sample from a
GP prior which can be integrated out to compute the data likelihood. The model
can be seen as an extension of a previous model applied to transcription factor
target identification [11]. Unlike Ref. [11], we model p(t) as a GP defined as an
integral of a function having a GP prior with RBF covariance, which implies that
p(t) tends to remain constant between observed data instead of reverting back
to the mean. Additionally we introduce the delay between pol-II concentration
and mRNA production as well as model the initial mRNA concentration as
an independent parameter. In the special case where ∆ = 0, and m0 = β0/α,
Eqn. (S3) reduces to the previous model (Eqn. 4 in [11]). In order to fit the model
to pol-II and mRNA time course data sampled at discrete times, we assume we
observe m(t) and p(t) corrupted by zero-mean Gaussian noise independently
sampled for each time point. We assume the pol-II noise variance is a constant
σ2p and infer it as a parameter of the model. The mRNA noise variances for
each time point are sums of a shared constant σ2m and a fixed variance inferred
by BitSeq by combining the technical quantification uncertainty from BitSeq
expression estimation with an estimate of biological variance from the BitSeq
differential expression model (full details in Supplementary Material).
Given the differential equation parameters, GP inference yields a full pos-
terior distribution over the shape of the Pol-II and mRNA functions p(t) and
m(t). We infer the differential equation parameters from the data using MCMC
sampling which allows us to assign a level of uncertainty to our parameter es-
timates. To infer a full posterior over the differential equation parameters β0,
β, α, ∆, m0, E[p0] = µp, the observation model parameters σ
2
p, σ
2
m, and a
magnitude parameter Cp and width parameter l of the GP prior, we set near-
flat priors for them over reasonable value ranges, except for the delay ∆ whose
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prior is biased toward 0 (exact ranges and full details are presented in Sup-
plementary Material). We combine these priors with the likelihood obtained
from the GP model after marginalising out p(t) and m(t), which can be per-
formed analytically. We infer the posterior over the parameters by Hamiltonian
MCMC sampling. This full MCMC approach utilises gradients of the distri-
butions for efficient sampling and rigorously takes uncertainty over differential
equation parameters into account. Thus the final posterior accounts for both
the uncertainty about differential equation parameters, and uncertainty over
the underlying functions for each differential equation. We ran 4 parallel chains
starting from different random initial states for convergence checking using the
potential scale reduction factor of [21]. We obtained 500 samples from each of
the 4 chains after discarding the first half of the samples as burn-in and thin-
ning by a factor of 10. Posterior distributions over the functions p(t) and m(t)
are obtained by sampling 500 realisations of p(t) and m(t) for each parameter
sample from the exact Gaussian conditional posterior given the parameters in
the sample. The resulting posteriors for p(t) and m(t) are non-Gaussian, and
are summarised by posterior mean and posterior quantiles. Full details of the
MCMC procedure are in Supplementary Material.
5.6 Filtering of results
Genes satisfying the following conditions were kept for full analysis. (Full im-
plementation details of each step are in Supplementary Material.)
1. p(t) has the maximal peak in the densely sampled region between 1 min
and 160 min.
2. Estimated posterior median delay is less than 120 min.
3. p(t) does not change too much before t = 0 min to match the known start
in steady state.
5.7 Analysis of the gene annotation features associated
with the delays
Ensembl version 68 annotations were used to derive features of all genes. For
each annotated transcript, we computed the total pre-mRNA length m as the
distance from the start of the first exon to the end of the last exon, and the
lengths of all the introns. Transcripts consisting only of a single exon (and hence
no introns) were excluded from further analysis. For each gene, we identified
the transcript with the longest pre-mRNA and used that as the representative
transcript for that gene. The last intron share f was defined as the length of
the last intron of the longest transcript divided by m.
5.8 Pre-mRNA end accumulation index
For this analysis, we only considered reads aligning uniquely to pre-mRNA
transcripts and not to any mRNA transcripts. We counted the overlap of reads
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with 200 bp bins starting from the beginning of the first exon of each gene
ending with the last non-empty bin. We compute the fraction re,i of all reads in
the latter half of bins in each sample i, and define the index as the difference of
the means of re,i over late time points (80-320 min) and over early time points
(10-40 min).
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Supplementary material
In the following we provide details of data acquisition, processing of RNA-seq
data and filtering of active genes, processing of pol-II ChIP-seq data, differential
equation modelling of the connection between pol-II and mRNA, Gaussian pro-
cess based inference of underlying time series, and summarisation and filtering
of results. We then provide an explanation of how synthetic data were used to
study accuracy of parameter estimation for mRNA half life, a measure of mRNA
decay in the differential equation model between pol-II and mRNA. Lastly, we
provide additional figures about tail probabilities of delays for alternative result
filtering choices, an additional figure about long posterior mean delays with and
without annotated exon skipping, and differences in pre-mRNA accumulation
in short and long delay genes.
A Data acquisition
MCF-7 breast cancer cells were treated with estradiol (E2). The cells were put
in estradiol free media for three days. This is defined media devoid of phenol
red (which is estrogenic) containing 2% charcoal stripped foetal calf serum. The
charcoal absorbs estradiol but not other essential serum components, such as
growth factors. This resulted in basal levels of transcription from E2 dependent
genes. The cells were then incubated with E2 containing media, which resulted
in the stimulation of estrogen responsive genes. Measurements were taken at
logarithmically spaced time points 0, 5, 10, 20, . . . , 1280 minutes after E2
stimulation.
At each time point, the pol-II occupancy was measured genome-wide by
ChIP-seq. Raw reads were mapped onto the human genome reference sequence
(NCBI build37) using the Genomatix Mining Station (software version 3.5.2).
The mapping software is an index-based mapper using a shortest unique sub-
word index generated from the reference to identify possible read positions. A
subsequent alignment step is then used to get the highest-scoring match(es) ac-
cording to the parameters used. We used a minimum alignment quality thresh-
old of 92% for mapping, reads were not trimmed. On average 84% percent of
reads could be mapped uniquely.
At each time point, the pre-mRNA and mature mRNA abundances were
measured for each human gene by RNA-seq. Total RNA was isolated and sub-
jected to rRNA depletion with the Ribo-Zero Magnetic Gold Kit and processed
further for strand-specific RNA-seq. The RNA-seq reads were mapped using
Bowtie to a transcriptome constructed from Ensembl version 68 annotation al-
lowing at most 3 mismatches and ignoring reads with more than 100 alignments.
The transcriptome was formed by combining the cDNA and ncRNA transcrip-
tomes with pre-mRNA sequences containing the full genomic sequence from the
beginning of the first annotated exon to the end of the last annotated exon. On
average 84.7% of the RNA-seq reads were mapped.
All the ChIP-seq and RNA-seq data are available from the NCBI Gene
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Expression Omnibus under accession number GSE62789.
B RNA-seq data processing
RNA-seq data were analysed at each time point separately using BitSeq [12].
The reads were first mapped to human reference transcriptome (Ensembl v68)
using Bowtie version 0.12.7 [22]. In order to separate pre-mRNA activity as
well, we augmented the reference transcriptome with pre-mRNA transcripts for
each gene that consisted of the genomic sequence from the beginning of the first
exon to the end of the last exon of the gene.
BitSeq uses a probabilistic model to probabilistically assign multimapping
reads to transcript isoforms [12], in our case also including the pre-mRNA tran-
scripts. We obtained gene expression estimates by adding the corresponding
mRNA transcript expression levels. In addition to the mean expression lev-
els, BitSeq provides variances of the transcript isoform expression levels. We
further used the biological variance estimation procedure from BitSeq differen-
tial expression analysis on the estimated gene expression levels by treating the
first three time points (0, 5, 10 min) as biological replicates. Genes with sim-
ilar mean expression levels (log-RPKM) were grouped together such that each
group contained 500 genes except for the last group with 571 genes with the
highest expression. Then, the biological variances were estimated for each group
of genes by using the Metropolis–Hastings algorithm used in BitSeq stage 2 [12].
Biological variances for the single measurements were determined according to
the gene expression levels at each time point, where each gene was considered to
belong to the closest gene group according to its expression level. The observa-
tion noise variance for each observation was defined as the sum of the technical
(BitSeq stage 1) and biological (BitSeq stage 2) variances, and transformed from
log-expression to raw expression using
σ2raw = σ
2
log exp(µlog)
2. (S1)
Different time points of the RNA-seq time series were normalised using the
method of [20] as implemented in the edgeR R/Bioconductor package [23].
Statistics of RNA-seq mapping and distribution of reads for pre-mRNA and
mRNA transcripts are presented in Tables S2 and S3 as well as Fig. S9.
C Filtering of active genes
We removed genes with no clear time-dependent activity by fitting time-dependent
Gaussian process models to the activity curves and only keeping genes with
Bayes factor at least 3 in favour of the time-dependent model compared to a
null model with no time dependence. We also removed genes that had no pol-II
observations at 2 or more time points. This left 4420 genes for which we fitted
the models.
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D Pol II ChIP-seq data processing
The ChIP-seq data were processed into time series by summarising the pol-II
occupancy over time for each human gene (Ensembl version 68 annotation was
used for gene positions), by a series of steps as follows.
1. Each gene was divided into 200 bp bins and levels of pol-II activity were
computed at each time point as the total weighted count of reads overlap-
ping each bin, where each read was weighted by how many basepairs in the
read overlap the bin, as follows. Only uniquely mapped reads were used.
For any read that at least partially overlaps a bin, the number of basepairs
overlapping the bin was added into the activity level of the bin. For any
read spanning multiple bins, the number of basepairs overlapping each bin
were added into activity of that bin. The Genomatix mapping software
provides alignment scores (values between 0 and 1; with our threshold
only between 0.92 and 1) for mapping reads to the genome; for any read
having alignment score less than 1, the number of overlapping basepairs
added to each bin was multiplied by the alignment score.
2. A noise removal was then done: a noise level was computed as the average
activity level in 74 manually selected regions from Chromosome 1 that
were visually determined to be inactive over the measurement time points,
as follows. The regions were divided into 200 bp bins, and total weighted
counts of reads overlapping each bin (each read weighted by the number
of basepairs overlapping the bin) were computed in the same way as for
the genes in the previous step. For each time point, the noise level was
computed as the average activity level over all bins from all 74 regions.
The computed noise level was subtracted from the mean of each bin in
each gene, thresholding the result at zero. A list of the empty regions used
is included as a Supplementary Dataset S1.
3. As the number of ChIP-seq reads collected overall for pol-II varies between
time points, a robust normalisation was done. After the previous noise
removal step, for each gene g at each time t we compute the mean of
the remaining activity (activity level after noise removal) over bins of the
gene, denoted as rgt. The activity levels are weighted counts of basepairs
from reads overlapping the gene; we select genes having sufficient activity,
that is, at least 5 · 200 overlapping basepairs from reads over each 200 bp
bin of the gene, on average over the bins. For each gene g let Tg = {t′ ∈
{5, 10, . . . , 1280 min}|rgt′ > 5 · 200} denote those time points (except the
first time point) where the gene has sufficient activity. For each time point
we compute a normalisation factor of [20]
Ct = Mediang
{
rgt
GeomMeant′{rgt′}
}
.
where Mediang{·} denotes median over genes and
GeomMeant′{rgt′} = (
∏
t′∈Tg rgt′)
1/|Tg| is the geometric mean over the
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time points having sufficient activity for gene g. The median is com-
puted for time points after the first time point; for the first time point
t = 0 min we set Ct = 1. The factor Ct normalises all the gene activity
levels (weighted read counts) at a time point downwards if genes at that
time point have unusually many reads, exceeding their (geometric) mean
activity level, and normalises upwards if gene activity levels fall under
their mean activity level.
4. Lastly, time series summaries were computed for pol-II at each gene. For
each gene at each time point t, the mean activity level (weighted read-
count) of pol-II over bins in the 20% section of the gene nearest to tran-
scription end was computed, normalised by Ct. This measured pol-II level
represents transcriptional activity that had successfully passed through
the gene to the transcription end site; it is expected to correspond better
with mRNA production rate than pol-II activity at the transcription start
of the gene, since pol-II near the transcription start site can be in the
active or inactive state and after activation may require a significant time
for transcription to complete.
5. For a small number of genes where the active mRNA transcripts covered
only part of the gene, we considered the area from the first active exon to
last active exon, and summarised the gene using the 20% section nearest
to the end of the area. Active transcripts were defined here as transcripts
with a mean of more than 1.1 assigned counts in the BitSeq posterior
expression estimates. BitSeq uses a prior that assigns 1 “pseudo-count”
per transcript, so the active transcripts were only required to have minimal
posterior expression that was distinguishable from the prior. A list of
active transcripts is included as Supplementary Dataset S2.
6. Lastly, for mathematical convenience, for each pol-II time series we sub-
tracted from all time points the minimum value over the time points.
E Differential equation based modelling
We model the role of pol-II as a catalyst of the transcription of DNA into
mRNA as a differential equation for each gene; the differential equation relates
the pol-II time series p(t) of the gene and the corresponding mRNA time series
m(t).
Let us assume the momentary pol-II activity directly represents the momen-
tary rate of transcription, potentially with a delay, and that the mRNA decays
at a constant rate. We model this as a linear differential equation
dm(t)
dt
= β0 + βp(t−∆)− αm(t) (S2)
where ∆ is a delay parameter between the pol-II activity and the momentary
transcription rate, β0 is a parameter representing the baseline transcription rate
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from unobservable pol-II background (baseline production level of mRNA), β
is a parameter representing transcriptional efficiency, that is, sensitivity of the
transcription rate to activity of pol-II, and α is a constant mRNA decay rate
parameter that is related to mRNA half-life t1/2 through α = ln(2)/t1/2.
The momentary mRNA level m(t) can be solved from the differential equa-
tion to yield the following solution:
m(t) = m0e
α(t0−t) +
β0
α
(
1− e−αt)+ βe−αt ∫ t
u=0 min
eαup(u−∆)du (S3)
where pol-II activity is assumed to start at t = 0 min (p(t) = 0 for t < 0 min),
t0  0 min is the time of the first observation, and m0 is an initial mRNA
abundance at t0 which is inferred as a parameter of the model. No parametric
assumptions are made about the shape of the pol-II time series function p(t),
and the only assumption about the mRNA level m(t) is that it arises through
the differential equation.
The linear differential equation (S2) and its linear solution operator (S3)
are similar to those used previously in [9–11] except for the added delay. As
in the previous works, the linearity of the solution operator permits exact joint
Gaussian process (GP) modelling over p(t) and m(t).
F Gaussian process inference
We model pol-II and mRNA time series, p(t) and m(t), in a nonparametric
fashion which avoids the assumption of a specific parametric shape for the time
series function; instead, we set a GP prior over the time series functions.
For each gene, GP inference of the posterior distribution over the underlying
pol-II and mRNA time series can be done in closed form given fixed values of the
differential equation parameters. GP inference is based on mean and covariance
functions. Below we describe the GP model of pol-II and mRNA, their respec-
tive mean functions and covariance functions, and the cross-covariance function
between pol-II and mRNA. GP inference of the posterior is then a standard
inference equation which we provide for completeness.
The above inference provides a posterior distribution over the profiles p(t)
and m(t) given known values for the differential equation parameters. However,
these values are not known and to infer a full posterior over both time series and
these parameters we carry out Markov Chain Monte Carlo (MCMC) sampling
over the parameter values, as described in Section “Parameter inference by
Hamiltonian Monte Carlo sampling”.
F.1 GP model of pol-II
For each gene, we model the pol-II activity time series in a nonparametric
fashion by applying a GP prior over the shapes of the time series. Previous
similar GP models [9–11] have used a squared exponential covariance function
for p(t), as that allows derivation of all the shared covariances in closed form.
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This covariance has the limitation that it is stationary, and functions following it
revert to zero away from data. These properties severely degrade its performance
on our highly unevenly sampled data. To avoid this, we model p(t) as an integral
of a function having a GP prior with a squared exponential covariance: then the
posterior mean of p(t) tends to remain constant between observed data. That
is, we model
p(t) = p0 +
∫ t
u=0
v(t)dt (S4)
where p0 is the initial value at time t = 0 min, and assign a GP prior with
the squared exponential covariance over v(t); as a result p(t) will also have a
GP prior whose covariance function is an integral of the covariance function
of v(t). For mathematical convenience we assume p(t) = 0 min for t < 0 min,
and set the initial observation time t0 to a sufficiently large value to avoid any
discontinuity resulting from assumption in pol-II or mRNA modeling.
To define the GP prior, we first define the mean function of p(t). Assume that
v(t) is drawn from a zero-mean GP prior with a squared exponential covariance
function kv(t, t
′) = Cp · exp(−(t − t′)2/l2) where Cp is a magnitude parameter
and l is a length scale, which has been parametrised in a non-standard manner
to simplify the derivations. Then E[p(t)] = E[p0]+
∫ t
u=t0
E[v(t)]dt = E[p0] ≡ µp
for t ≥ 0 min.
Next we compute the corresponding covariance function for the GP prior of
p(t). We have
kp(t, t
′) ≡ E[(p(t)− µp)(p(t′)− µp)] =
∫ t
s=0
∫ t′
s′=0
kv(s, s
′)dsds′
=
√
piCpl
2
∫ t
s=0
(
erf((t′ − s)/l)− erf(−s/l)
)
ds (S5)
The remaining integral over the erf functions can be computed using inte-
gration by parts. After straightforward manipulation, the integral becomes
kp(t, t
′) =
Cp
√
pil2
2
(
tlerf (tl) + t
′
lerf (t
′
l)− (t′l − tl)erf (t′l − tl)
)
+
Cpl
2
2
(
exp
(−t2l )+ exp (−(t′l)2)− exp (−(t′l − tl)2)− 1) . (S6)
where we denoted tl = t/l and t
′
l = t
′/l for brevity.
The right-hand side is the covariance function kp(t, t
′) of the
integrated squared-exponential GP prior for pol-II.
F.2 GP model of mRNA
We model the mRNA abundance in a similar nonparametric fashion as the pol-
II activity. Since the mRNA is related to pol-II through a differential equation,
the GP prior of mRNA can be computed from the GP prior of pol-II through the
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differential equation. In particular, as shown in Eq. (S3), the mRNA time series
is an integral of the pol-II time series. Since integration is a linear operation,
the expected mRNA time series is an integral of the expected pol-II time series;
that is, the GP mean function of mRNA is an integral of the mean function of
pol-II, so that
µm(t) ≡ E[m(t)] = m0eα(t0−t)+
β0
α
(
1− e−αt)+ βe−αt ∫ t
u=0
eαuE[p(u−∆)]du
= m0e
−α(t−t0) +
β0
α
(
1− e−αt)+ βe−αt ∫ t
u=∆
eαuµpdu
= m0e
−α(t−t0) +
β0
α
(
1− e−αt)+ βµp
α
(1− e−α(t−∆)) (S7)
where the third line follows since pol-II activity starts at t = 0 min. Note that
the start of pol-II activity at t = 0 min is for mathematical convenience, and
the initial observation time t0 will be set to a sufficiently large value so that the
t − ∆ ≥ 0 min for all t ≥ t0 and hence observed mRNA values are integrated
over active pol-II only regardless of delay ∆.
We next compute the corresponding covariance function for the GP prior
of mRNA. The covariance function arises from computing the integral relating
mRNA to pol-II as follows:
km(t, t
′) ≡ E[(m(t)− µm(t))(m(t′)− µm(t′))]
= E
[(
βe−αt
∫ t
u=0
eαup(u−∆)du− βµp
α
(1− e−α(t−∆))
)
(
βe−αt
′
∫ t′
u′=0
eαu
′
p(u′ −∆)du′ − βµp
α
(1− e−α(t′−∆))
)]
= β2E
[(
e−αt
∫ t
u=∆
eαup(u−∆)du− µp
α
(1− e−α(t−∆))
)
(
e−αt
′
∫ t′
u′=∆
eαu
′
p(u′ −∆)du′ − µp
α
(1− e−α(t′−∆))
)]
(S8)
where the last equality follows since pol-II activity starts at time 0 min. The
computation of the integrals follows similar steps as computation of the pol-II
GP covariance. The result is
km(t, t
′) = km,1(t, t′) + km,2(t, t′) + km,3(t, t′) + km,4(t, t′) (S9)
where we divided the covariance function into four parts. The first part is
km,1(t, t
′) =
√
pilCpβ
2
2α2
((
t∆ − 1
α
+
exp(−αt′∆)
α
)
erf
(
t∆
l
)
+
(
t′∆ −
1
α
+
exp(−αt∆)
α
)
erf
(
t′∆
l
)
− (t∆ − t′∆)erf
(
t∆ − t′∆
l
))
(S10)
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where t∆ = max(0 min, t−∆). The second part is
km,2(t, t
′) =
l2Cpβ
2
2α2
(
exp
(
−
(
t∆
l
)2)
+ exp
(
−
(
t′∆
l
)2)
− exp
(
−
(
t∆ − t′∆
l
)2)
− 1
)
. (S11)
The third part is
km,3(t, t
′) = −√pilCpβ2
(
α−3
4
exp(α2l2/4 + α(t∆ − t′∆))
(erf(αl/2 + t∆/l)− erf
(
αl/2 + (t∆ − t′∆)/l)
)
+
α−3
4
exp(α2l2/4− αt′∆ − αt∆)
(
erf(αl/2)− erf(αl/2− t′∆/l)
)
− α
−3
2
exp(α2l2/4− αt′∆)
(
erf(αl/2)− erf(αl/2− t′∆/l)
))
. (S12)
The fourth part is
km,4(t, t
′) = −√pilCpβ2
(
α−3
4
exp(α2l2/4− α(t∆ − t′∆))(
erf(αl/2 + t′∆/l)− erf(αl/2− (t∆ − t′∆)/l)
)
+
α−3
4
exp(α2l2/4− αt∆ − αt′∆)
(
erf(αl/2)− erf(αl/2− t∆/l)
)
− α
−3
2
exp(α2l2/4− αt∆)
(
erf(αl/2)− erf(αl/2− t∆/l)
))
. (S13)
F.3 GP joint model
To define the full GP prior over both pol-II and mRNA, it remains to define the
cross-covariance function between pol-II and mRNA. The full GP covariance
is defined by the individual covariances of pol-II and mRNA and the cross-
covariance.
The cross-covariance function between (noiseless) mRNA abundance m(t)
at time t and (noiseless) pol-II activity p(t′) at time t′ is computed with similar
steps as the computation of the mRNA covariance function. The result is
kmp(t, t
′) = E[(m(t)− µm(t))(p(t′)− µp(t′))]
= kmp,1(t, t
′) + kmp,2(t, t′) + kmp,3(t, t′) (S14)
where for convenience we separated the kernel function into a sum of three
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components. The first component part of the kernel can be written as
kmp,1(t, t
′) =
−
√
piβ2
√
Cpl
2α2
exp
((
αl
2
)2
− αt∆ + αt′
)
·
[
erf
(
αl
2
+
t′
l
)
− erf
(
αl
2
+
t′ − t∆
l
)]
−
√
piβ2
√
Cpl
2α2
exp
((
αl
2
)2
− αt∆
)
·
[
erf
(
αl
2
− t∆
l
)
− erf
(
αl
2
)]
. (S15)
The second component can be written as
kmp,2(t, t
′) =
− β
2
√
Cpl
2
2α
[
exp
(
−
(
t∆ − t′
l
)2)
− exp
(
−
(
t∆
l
)2)
+ 1− exp
(
−
(
t′
l
)2)]
. (S16)
The third component can be written as
kmp,3(t, t
′) = −
√
piβ2
√
Cpl
2α
[
(t∆ − t′ − 1/α)erf((t∆ − t′)/l)
− (t∆ − 1/α)erf(t∆/l)− (t′ + exp(−αt∆)/α)erf(t′/l)
]
. (S17)
F.4 Observation model
In order to fit the models of the pol-II and mRNA functions to observations,
we need an observation model. It is assumed that we observe noisy values
m˜(t) = m(t) + em(t) and p˜(t) = p(t) + ep(t) where em(t) and ep(t) are zero-
mean Gaussian noise independently sampled for each time point. For simplicity
we assume the noise variance of ep(t) is a constant σ
2
p and infer it as a parameter
of the model. We estimate the mRNA noise variances σ2m(t) for each time point
t as sums of a shared constant σ2m and a fixed variance inferred by BitSeq
by combining the technical quantification uncertainty from BitSeq expression
estimation with an estimate of biological variance from the BitSeq differential
expression model (full details are in Sec. RNA-seq data processing).
Since the noise is zero-mean, the GP prior for the noisy observations has the
same means as the noiseless means, that is, E[m˜(t)] = E[m(t)] and E[p˜(t)] =
E[p(t)]. Since the noise is independently added to each observation, the covari-
ance function of observed pol-II becomes
kp˜(t, t
′) = kp(t, t′) + δ(t, t′)σ2p (S18)
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where δ(t, t′) = 1 if t = t′ and zero otherwise, the covariance function of observed
mRNA becomes
km˜(t, t
′) = km(t, t′) + δ(t, t′)σ2m(t) , (S19)
and the cross-covariance function between observed pol-II and mRNA is the
same as the noiseless version so that
km˜p˜(t, t
′) = kmp(t, t′) . (S20)
The GP prior over time series functions and the observation model together
define a full probability model for the pol-II and mRNA data. As the observa-
tions are noisy and available only at a small set of time points, we will apply
Bayesian inference to infer the underlying time series m(t) and p(t) from the
observations.
F.5 Covariance matrix for GP inference
Given a set of time points, here the 10 time points
Tobs = t0 + (0, 5, 10, 20, 40, 80, 160, 320, 640, 1280)
= (t1, . . . , tN )
where t0 is the initial observation time and the numbers denote time in minutes,
and the corresponding observation data consisting of N = 10 pol-II observations
and N = 10 mRNA observations D = (p˜(t1), . . . , p˜(tN ), m˜(t1), . . . , m˜(tN )), we
wish to compute the posterior distribution of GP hyperparameters, and to pre-
dict the shape of the underlying time series functions p(t) and m(t) given the
posterior. We will especially wish to study delay between pol-II and mRNA;
for mathematical convenience we set t0 = 300 min and consider mRNA delay
parameters 0 ≤ ∆ ≤ 300 min.
For GP inference, given the hyperparameters we must compute the prior
GP covariance matrix for the observations D. We describe the matrix here
in a general form which is needed later for inference of time series values at
previously unseen time points.
The covariance matrix describes covariance between measurements at one set
of time points (indexed by rows of the matrix) and another set of time points (in-
dexed by columns of the matrix). Let Trow = (trow,1, . . . , trow,Nrow) be a vector
of Nrow time indices for rows of the matrix, and let Tcol = (tcol,1, . . . , tcol,Ncol)
be the vector of Nrow time indices for columns of the matrix.
The resulting covariance matrix K(Trow, Tcol) has the block structure
K(Trow, Tcol) =
[
Kp˜ Kp˜m˜
Km˜p˜ Km˜
]
(S21)
where each block is a Nrow ×Ncol matrix of covariance function values between
the time points t ∈ Trow and the time points t′ ∈ Tcol, so that Kp˜ is composed
of values kp˜(t, t
′), Km˜ is composed of values km˜(t, t′), Km˜p˜ is composed of the
cross-covariance values km˜p˜(t, t
′), and Kp˜m˜ is composed of the cross-covariance
values km˜p˜(t
′, t). The covariance matrix of observed data is then simply Kobs =
K(Tobs, Tobs).
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F.6 Marginal likelihood function
The analytical tractability of the GP model allows us to marginalise out the la-
tent functions p(t) and m(t) to compute a marginal likelihood that only depends
on the model parameters. The marginal probability density of the observations
D is Gaussian and the marginal log-likelihood is
logP (D) = (1/2)(−d log(2pi)− log(|Kobs|)− u>K−1obsu) (S22)
where P denotes the marginal probability density, d = 20 is the total num-
ber of pol-II and mRNA observations and u is the column vector of observa-
tions with their expected values subtracted, u =
[
p˜(t1) − E[p˜(t1)], . . . , p˜(tN ) −
E[p˜(tN )], m˜(t1)− E[m˜(t1)], . . . , m˜(tN )− E[m˜(tN )]
]>
.
F.7 Posterior prediction
The analytical tractability of the GP model also allows us to obtain the full
posterior distribution over the latent functions in closed form given the param-
eters. Given the observed data, we can thus compute the mean and covariance
of the underlying time series function values at each time point, as expectations
over the posterior distribution of the underlying functions. For N∗ new time
points T ∗ = (t∗1, . . . , t
∗
N∗) the posterior mean is
E[[p˜(t∗1), . . . , p˜(t
∗
N∗), m˜(t
∗
1), . . . , m˜(t
∗
N∗)]|D] = u∗prior +K(T ∗, Tobs)K−1obsu (S23)
where
u∗prior =
[
E[p˜(t∗1)], . . . , E[p˜(t
∗
N∗)], E[m˜(t
∗
1)], . . . , E[m˜(t
∗
N∗)]
]>
(S24)
is the vector of prior means computed at the new time points, and the posterior
covariance matrix is
Cov[(p˜(t∗1), . . . , p˜(t
∗
N∗), m˜(t
∗
1), . . . , m˜(t
∗
N∗))|D]
= K(T ∗, T ∗)−K(T ∗, Tobs)K−1obsK(T ∗, Tobs)> . (S25)
The log-likelihood and predictions of function values described here are com-
puted given fixed values of hyperparameters of the GP prior and the observation
model. We will compute a posterior distribution for the hyperparameters, given
suitable prior distributions for each. This will allow summarisation of underlying
pol-II and mRNA functions and GP parameters over the posterior distribution
of the hyperparameters. We next describe the prior distributions of hyperpa-
rameters and then describe the sampling based inference of hyperparameter
posterior distributions.
F.8 Parameter prior distributions
All parameters except the delay ∆ have approximately uniform bounded logistic-
normal priors. These priors were used because of convenience: they allow easy
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Hamiltonian Monte Carlo sampling that requires very little tuning (see below
for details).
The density of the logistic-normal prior logit-normal(µ, σ2, a, b) with location
parameter µ and scale parameter σ2 for variable θ bounded to the interval [a, b]
is
p(θ|µ, σ2, a, b) =
1√
2piσ2
exp
(
− (logit((θ − a)/(b− a))− µ)
2
2σ2
)
· b− a
(θ − a)(b− θ) , (S26)
where logit(x) = log(x/(1 − x)). We use µ = 0 and σ = 2 which lead to an
approximately uniform distribution on the interval [a, b]. The interval bounds
a, b for all variables are presented in Table S1.
For the delay ∆ we use a prior with µ = −2, σ = 2 to reflect our prior belief
that the delays should in most cases be small. For β and l we set the priors
with respect to β2 and 2/l2 respectively, because these are more convenient as
model parameters.
Parameter Lower bound a Upper bound b
2/l2 (1280 min)−2 (5 min)−2
≈ 6.1 · 10−7 min−2 = 4 · 10−2 min−2
Cp 2 · 10−4 σˆ2Pol2 σˆ2Pol2
σ2p 0.05σˆ
2
Pol2 σˆ
2
Pol2
α 1 · 10−6 min−1 log(2) min−1 ≈ 0.69 min−1
β2 1 · 10−6 min−2 1 min−2
∆ 0 min 299 min
β0 0 min
−1 1 min−1
m0 0 2
µp 0 1
Table S1: Bounds for bounded logistic-normal priors of differential equation
parameters in the GP inference of pol-II and mRNA time series. Each parameter
is bounded to an interval [a, b], we list the values of the lower bound a and
upper bound b. Here σˆ2Pol2 is the empirical variance of the pol-II time series
after preprocessing.
F.9 Parameter inference by Hamiltonian Monte Carlo sam-
pling
Given the data and the priors for the parameters, we apply fully Bayesian in-
ference with Hamiltonian Monte Carlo (HMC) sampling [15] to obtain samples
from the posterior distribution of the parameters. HMC is a MCMC algorithm
that uses gradients of the target distribution to simulate a Hamiltonian dynami-
cal system with an energy function based on the target distribution. This allows
taking long steps while maintaining a high acceptance rate in the sampling.
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In order to apply HMC more easily, we transform all parameters to an un-
bounded space using the logistic transformation. The logistic-normal priors cor-
respond to normal priors on the transformed variables, which effectively prevent
the sampler from wandering off to the saturated region of the transformation
near the bounds of the intervals.
We run 4 parallel chains starting from different random initial states to allow
convergence checking. We use the HMC implementation from NETLAB toolkit
in Matlab with momentum persistence and number of leap frog steps τ = 20
which were found to work well in all cases. The step length  is tuned separately
for every model (see below). After tuning, each chain is run for 10000 iterations.
The samples are then thinned by a factor of 10, and the first half of the samples
are discarded, leaving 500 samples from each chain, 2000 in all. Convergence is
monitored using the potential scale reduction factor
√
Rˆ [21].
√
Rˆ is computed
separately for each variable, and if any of them is greater than 1.2, the result
is discarded and a new sample obtained in a similar manner. The 9 genes that
did not converge after 10 iterations of this process were removed from further
analysis. In most cases these had severely multimodal delay distributions that
were difficult to sample from and would have made further analysis difficult.
F.9.1 Tuning
The applied logistic transformation and priors together allow using the same
global step length  for all variables, or using the identity matrix as the mass ma-
trix in the HMC formulation. The step length  was determined by trying differ-
ent alternatives in the set {10−5, 10−4, 10−3, 0.003, 0.005, 0.01, 0.03, 0.05, 0.07, 0.1,
0.3, 0.5, 1} in increasing order, running the sampler for 100 steps and using the
largest value with at least 80% acceptance rate. This target rate is higher than
usual in random walk MCMC because HMC acceptance rate should be nearly
100% even with very long steps if the Hamiltonian system is simulated accu-
rately.
F.9.2 Summarisation of inference results
The inference results are summarised using the median of the posterior samples.
This is a convenient statistic because it is invariant to transformations of the
parameter space, such as those used during the sampling.
F.10 Validation of the GP modelling results
In order to validate the GP model, we implemented inference for the same ODE
using a smoothing spline fit for pol-II. A comparison of the results for the subset
of genes that yielded reliable results with the spline approach is presented in
Fig. S10.
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G Filtering of results
Reliable posterior samples were obtained for models of 4373 genes. 4304 of
these had multiple-exon transcripts, and could thus be used for intron analyses.
These genes were further filtered to remove bad fits by only keeping genes that
satisfy the following:
1. The global maximum tmax of p(t) posterior mean p¯(t) in the interval t ∈
[0 min, 1280 min] occurs in the interval tmax ∈ (1 min, 160 min). This
condition ensures the profile has a peak in the densely sampled region
which is necessary for accurate estimation of the delay.
2. The posterior median delay ∆ˆ < 120 min. Because of the increasingly
sparse sampling, longer delay estimates were considered unreliable. The
specific cut-off was determined by visual inspection of the fits to rule out
implausible ones.
3. The posterior mean p¯(t) of p(t) does not change too much just before
t = 0 min. This condition is necessary to avoid cases where a long delay
pushes distinctive features of m(t) to p(t), t < 0 min, which conflicts with
the assumption that the system is at a steady state until t = 0 min.
Quantitatively, we define an index
D = D− −D+ = D[−30 min,0 min] −D[0 min,10 min] (S27)
where
DI =
(
max
t∈I
[p¯(t)]−min
t∈I
[p¯(t)]
)
/ max
t∈[−30 min,1280 min]
[p¯(t)], (S28)
and only include genes with
D < 0.05. (S29)
Intuitively, DI looks at the magnitude of change in p¯(t) in the interval I
relative to the global magnitude of change in p¯(t). The final statistic D
looks for genes that have small changes in [−30 min, 0 min], but forgives
genes with early large changes in [0 min, 10 min] because these would often
spill over to t < 0 min because of the properties of the GP model. The
cut-off 0.05 represents 5% change in magnitude, which seems reasonably
small. The main conclusions of the work are robust to different cutoffs, as
demonstrated in Fig. S5 below.
After these filtering steps, there were 1814 genes left for the analysis.
Main results under an additional filter of setting a maximum for posterior
inter-quartile range are presented in Fig. S11.
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Figure S1: Boxplots of parameter posterior distributions illustrating parame-
ter estimation performance on synthetic data for the mRNA half life t1/2 =
log(2)/α. The strong black lines indicate the ground truth used in data genera-
tion. The box extends from 25th to 75th percentile of the posterior distribution
while the whiskers extend from 9th to 91st percentile. The model often under-
estimates the half lives, especially in the presence of a significant delay.
H Synthetic data generation
The synthetic data were generated by fitting a GP with the MLP covariance [24]
to the Pol-II measurements of the gene TIPARP (ENSG00000163659), and nu-
merically solving the mRNA level using Eq. (S3) with the GP posterior mean
as p(t). The parameters used were: ∆ ∈ {0, 10, 20, 30} min, t1/2 = log(2)/α ∈
{2, 4, 8, 16, 32, 64} min, β0 = 0.005, β = 0.03, m0 = 0.008/α. The parameter
values were chosen empirically to get profiles that approximately fitted the ac-
tual mRNA observations while looking reasonable and informative across the
entire range of parameter values.
I Supplementary Results
In this section we provide supplementary Figs. S1–S8 discussed in the main
paper as well as Figs. S9–S11 discussed in the Supplementary Methods.
I.1 Estimation of delays under changing mRNA half life
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Figure S2: Boxplots of parameter posterior distributions illustrating parameter
estimation performance on synthetic data for the delay parameter ∆. The
strong black lines indicate the ground truth used in data generation. The box
extends from 25th to 75th percentile of the posterior distribution while the
whiskers extend from 9th to 91st percentile. This is a counterpart of Fig. 3 in
a situation where the simulated mRNA half-life t1/2 changes during the time
course, something our model cannot capture. The simulated changes are point
changes up or down with a factor of 1.5 or 2 at 80 min. The results show
that delay estimates remain accurate and reliable, with the true value always in
the high posterior density region, and demonstrate the conservativeness of the
estimates with no sign of serious overestimation of small delays.
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Figure S3: An illustration of how proper summarisation of the RNA-seq data
is important for ruling out confounding effects from changing splicing patterns
during the experiment. Left: Gene expression time series of the gene OSGIN1
from RNA-seq data using either transcript-based RNA-seq data summarisation
as in the paper or using a simpler summarisation of counts of reads aligned
uniquely to the mRNA transcripts of OSGIN1. Centre: Proportion of tran-
script ENST00000563543 out of all OSGIN1 transcripts. At 567 bp, this mRNA
transcript is much shorter than the other major transcripts whose mRNAs are
around 2 kb. Right: The model fit for OSGIN1 shows no evidence of significant
delay, while the count-based profile in the left figure would suggest a longer
delay.
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Figure S4: Alternative versions of Fig. 5 of the main paper: tail probabilities for
delays for different cut-offs for D in Eq. (S29). Top: D < 0.05 (value used for
main results), middle: D < 0.1, bottom: D < 0.01. Left: genes whose longest
pre-mRNA transcript is short (m is the length from transcription start to end).
Right: genes with relatively long last introns (f is the ratio of the length of
the last intron of the longest annotated transcript of the gene divided by the
length of that transcript pre-mRNA). The fraction of genes with long delays ∆
is shown by the red and blue lines (left axis). In both subplots, the black curve
denotes the p-values of Fisher’s exact test conducted separately at each point
(right axis) with the dashed line denoting p < 0.05 significance threshold. The
general shapes of the curves are the same in every case.
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Figure S5: Alternative versions of Fig. 5 of the main paper: different cut-offs
for f and m. Left: genes whose longest pre-mRNA transcript is short (m is the
length from transcription start to end). Right: genes with relatively long last
introns (f is the ratio of the length of the last intron of the longest annotated
transcript of the gene divided by the length of that transcript pre-mRNA).
The fraction of genes with long delays ∆ is shown by the red and blue lines
(left axis). In both subplots, the black curve denotes the p-values of Fisher’s
exact test conducted separately at each point (right axis) with the dashed line
denoting p < 0.05 significance threshold. The general shapes of the curves are
the same in every case.
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Figure S6: Alternative versions of Fig. 5 (right) of the main paper: explore
the dependence on f for genes with a lower bound on mRNA length m. The
fraction of genes with long delays ∆ is shown by the red and blue lines (left
axis). The black curve denotes the p-values of Fisher’s exact test conducted
separately at each point (right axis) with the dashed line denoting p < 0.05
significance threshold. The general shapes of the curves are the same in every
case.
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Figure S7: Proportion of long posterior median delays for genes with/without
annotated exon skipping. The fraction of genes with long delays ∆ is shown by
the red (no skipped exons) and blue (skipped exons) lines (left axis). The black
curve denotes the p-values of Fisher’s exact test conducted separately at each
point (right axis) with the dashed line denoting p < 0.05 significance threshold.
There is no clear difference between the two groups.
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Figure S8: Alternative version of Fig. 6 (right) of the main paper: computing
the index based on pol-II ChIP-seq and GRO-seq instead of intronic RNA-seq
reads. The top plots show differences in the mean pol-II accumulation index in
long delay genes (blue) and short delay genes (red) as a function of the cut-off
used to distinguish the two groups (left axis). Positive values indicate increased
pol-II accumulation at the 3’ end (top left: last 50% of the gene body, top
right: last 5% of the gene body) over time. The black line shows the p-values of
Wilcoxon’s rank sum test between the two groups at each cut-off (right axis).
The bottom plot is the same as top right, except for GRO-seq data of [25], with
the index is defined as the difference between the only late (160 min) time point
and the average of the early (0-40 min) time points. In contrast to the pre-
mRNA figure in the main paper, both long and short delay genes show a clear
tendency towards accumulation of pol-II towards the end of the gene, but there
is no clear difference between the two groups for the last 50% (top left), while
there is a very consistent pattern of more pol-II accumulation very close to 3’
end (top right) for long delay genes, and the level is essentially independent of
the estimated delay. GRO-seq data in the last 5% (bottom) behave similarly as
pol-II ChIP-seq (top right).
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Figure S9: Distributions of per-gene mRNA and pre-mRNA counts and cover-
ages based on BitSeq expression estimates. Top two rows show broad distribu-
tions for all genes, while the bottom two rows show distributions biased toward
higher values for the selected 1786 genes. The results show that the mRNA
coverages are mostly clearly higher than for pre-mRNA, again demonstrating a
sensible split between pre-mRNA and mRNA.
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Figure S10: Comparison of estimated posterior median delays from the GP
model with an alternative spline-based model for n = 15 genes with reliable es-
timates. In this model we used cubic smoothing splines to fit continuous curves
to pol-II measurements. To account for the uneven sampling the times were
transformed as t′ = log(t/min + 5). The regularisation strength was shared
over all genes and optimised by leave-one-out cross validation over all internal
time points. The time transformation was also found to work much better than
untransformed time in the cross validation. The smoothed pol-II curves were
used as input to Eq. (S2) which was solved numerically to obtain predictions
for m(t). Assigning a Gaussian noise model to m(t) similar to the GP model
and using similar priors for all shared parameters, we run MCMC to obtain
posteriors over the parameters. We were only able to obtain reliable parameter
estimates for a small subset of genes for which the method had a good fit (mea-
sured through expected relative residual variance) for both pol-II and mRNA.
The other estimates were unreliable presumably because the method estimated
the pol-II profiles independently but then ignored the uncertainty related to this
estimation, which further highlights the benefits of the GP approach.
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Figure S11: Alternative versions of Figs. 5 and 6 under more stringent filtering
of delay posterior interquartile range (IQR).
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